header-decor
  • Simple Item 5
  • Simple Item 4
  • Simple Item 3
  • Simple Item 2
  • Simple Item 1
  • 1
  • 2
  • 3
  • 4
  • 5

FDA Clearance

August 2012

FDA has cleared for marketing in the U.S. Xenolith's device for use in procedures involving Intracorporeal Shock Wave Lithotripsy and patients diagnosed with kidney stones.

pdfDownload press release by VLSI, one of Xenolith's investors.

CE Mark

November 2011

Xenolith receives a CE mark for XenX™

ISO Certification

August 2011

Xenolith certified for ISO 13485

Certifications